Atlas Trials

Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer

Clinical trial NCT01727076 · COMPLETED

Trial details

NCT number
NCT01727076
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck CarcinomaRecurrent Non-Small Cell Lung CarcinomaRecurrent Renal Cell CarcinomaRecurrent Skin CarcinomaStage III Renal Cell CancerStage IIIA Cutaneous Melanoma AJCC v7Stage IIIA Non-Small Cell Lung Cancer AJCC v7Stage IIIB Cutaneous Melanoma AJCC v7Stage IIIB Non-Small Cell Lung Cancer AJCC v7Stage IIIC Cutaneous Melanoma AJCC v7Stage IV Cutaneous Melanoma AJCC v6 and v7
Start date
2013-02-15
Primary completion
2016-06-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.